Press releases and other news

Latest news and press releases

	Nomination committee proposes re-election of all board members 2010-02-24 16:30 - Pressrelease (pdf)
	Meda AB (publ) – 2009 year-end report 2010-02-16 08:00 - Annual Financial Statement (pdf)
	Meda in-licenses exclusive rights to Xerese™ 2010-02-15 15:00 - Pressrelease (pdf)
	Meda in-licenses exclusive rights to Ceplene 2010-01-11 08:00 - Pressrelease (pdf)
	FDA accepts NDA filing for Retigabine 2009-12-30 14:07 - Pressrelease (pdf)
	Meda expands Axorid collaboration 2009-12-30 10:00 - Pressrelease (pdf)
	Meda strengthens the financial headroom 2009-12-07 11:10 - Pressrelease (pdf)
	Meda AB (publ) - Interim report, January–September 2009 2009-11-03 08:00 - Quarterly report (pdf)
	Retigabine filings completed in the US and Europe 2009-11-02 14:13 - Pressrelease (pdf)
	Nomination committee appointed 2009-10-26 15:00 - Pressrelease (pdf)
	Onsolis filed in Canada 2009-10-02 13:00 - Pressrelease (pdf)
	Expanded rights for azelastine and fluticasone combination 2009-09-07 16:12 - Pressrelease (pdf)
	FDA approval of the first once-daily nasal antihistamine 2009-09-02 13:15 - Pressrelease (pdf)
	Meda AB (publ) – Interim report, January–June 2009 2009-08-18 08:00 - Half Year financial report (pdf)
	Onsolis receives FDA approval 2009-07-17 08:00 - Pressrelease (pdf)
	FDA approval for Onsolis anticipated during summer 2009 2009-06-15 08:30 - Pressrelease (pdf)
	Positive study supporting a potential once-daily nasal antihistamine 2009-05-28 11:15 - Pressrelease (pdf)
	Meda AB (publ) AGM bulletin 2009-05-05 20:30 - Minutes of annual general meeting (pdf)
	Meda AB (publ) – Interim report January–March 2009 2009-05-05 08:00 - Quarterly report (pdf)
	Meda AB (publ): Notification to shareholders of the annual general meeting 2009-04-07 08:00 - Notice to convene annual general meeting (pdf)